Ministerial approval allows overseas treatment after domestic options exhausted
In a decision made days before the provincial election was called, the B.C. health minister approved $400,000 in funding to allow a North Vancouver family to seek specialised treatment in Germany for their nine‑year‑old son’s rare brain disorder.
The family says the funding, confirmed to them by Health Minister Ravi Kahlon, removes an enormous financial obstacle to treatment that can cost roughly $70,000 per session. The boy, identified in media reports as Nathan Hepburn, has an arteriovenous malformation (AVM) deep in the thalamus — a vascular abnormality that can rupture and lead to devastating brain injury or death.
The child’s mother, Natasha Hepburn, a registered nurse, told the North Shore News the approval came as a massive relief and allowed the family to proceed with plans to travel for the specialised procedure. She said knowing the funding was in place meant she could focus on caring for her son and his treatment instead of worrying about how to pay for it.
“The news has lifted a significant weight off my shoulders and I can concentrate on just being a mom, taking care of Nathan, and focusing on his treatment in Germany, without having to worry about how I’m going to get my child there.”
Clinicians in Canada had assessed treatment options and determined that traditional surgery was not viable because the AVM sits too deep within the brain. Radiation was attempted but led to serious complications, and physicians advised there were no further recommended options domestically, the family reported.
What the treatment path looks like and local implications
Treatments for AVM can include surgical resection, targeted radiation or endovascular procedures that block abnormal vessels. In this case, the family pursued a clinic in Germany that offers specialised interventions not available or recommended in Canada for their son’s particular lesion and location. Each session at the overseas clinic is reported to cost about $70,000, and the approved provincial funding of $400,000 is intended to cover multiple treatments.
| Item | Amount |
|---|---|
| Approved provincial funding | $400,000 |
| Approximate cost per treatment session | $70,000 |
For North Vancouver families that face rare or complex conditions, this case highlights the intersection of clinical judgement, out‑of‑province referrals and provincial funding decisions. It also raises questions about the availability of highly specialised neurosurgical and neurointerventional services within the province and the mechanisms families must navigate to get approval for care abroad.
- Approval was communicated to the family by Health Minister Ravi Kahlon just before the provincial election call.
- The child’s AVM is located in the thalamus and was deemed inoperable due to depth.
- Radiation treatments in Canada produced serious complications and clinicians said no further domestic options were recommended.
Community and policy consequences
Local advocates for children with rare disorders often point to the strain of navigating complex care pathways and fundraising for treatments not readily available in Canada. The Hepburn family’s experience underscores how provincial approvals can be decisive for families racing against time and risk.
While the immediate outcome for this family depends on the success of the overseas intervention, the broader questions remain for North Vancouver residents: how are scarce specialised services prioritised within B.C., and what criteria guide approving publicly funded treatment abroad? Health system transparency and clear pathways for families seeking exceptional care were already topics of local concern; this case will likely renew attention to how those policies are applied and communicated.
The province, in this instance, moved to fund care the family says was no longer available domestically. What follows now for the Hepburns is preparing for travel and treatment, while the community watches for results and considers what the case reveals about access to high‑risk, high‑cost care for children in British Columbia.
